Among the conventional cancer therapies, carbon-ion radiotherapy is considered one of the best partners of anti-PD-1/PD-L1 treatment, because carbon-ion radiotherapy specifically targets solid tumors owing to the Bragg peak effect, whereas anti-PD-1/PD-L1 therapy is complementarily effective against metastases as well as solid tumors. Here, CD274 is linked to cancer.